Advanced Life Sciences to Host Conference Call to Update Investors on Progress of Corporate Initiatives on Octob...( CHICAGO Sept. 24 /- Advanced Life...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Advanced Life Sciences to Host Conference Call to Update Investors on Progress of Corporate Initiatives on October 1, 2008
Date:9/24/2008
CHICAGO, Sept. 24 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS) will conduct a conference call at 9:00 a.m. Eastern Time on Wednesday, October 1, 2008 to provide an update on third quarter milestone progress.
Conference Call Details
The conference call will be webcast live over the Internet. To access the webcast, visit the Investor Relations section of the Advanced Life Sciences corporate website at http://www.advancedlifesciences.com. Alternatively, investors may participate in the conference call by dialing 888-679-8018 (domestic) or 617-213-4845 (international). The passcode for the conference call is 99287584. A replay of the conference call will be available until October 8, 2008. Callers may access the telephone replay by dialing 888-286-8010 (domestic) or 617-801-6888 (international), passcode 29205976. Investors are advised to dial into the call at least ten minutes prior to the call to register. Participants may pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=P88ATW9XX. Pre-registrants will be issued a pin number to use when dialing into the live call which will provide quick access to the conference by bypassing the operator upon connection.
About Advanced Life Sciences
Advanced Life Sciences is a biopharmaceutical company engaged in the
discovery, development and commercialization of novel drugs in the
therapeutic areas of infection, cancer and respiratory diseases. The
Company's lead candidate, cethromycin, is a novel once-a-day oral
antibiotic in late-stage deve
'/>"/>
| SOURCE Advanced Life Sciences Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Advanced Chemical Transport Opens Merced Facility
2. Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma
3. Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services
4. Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment
5. Waters Brings Advanced Laboratory Data Management to Microsofts BioIT Alliance
6. LUMEDX Introduces Advanced Multi-Modality, Multi-Vendor, Web-Enabled ECG Management Solution
7. Advanced Life Sciences Announces Second Quarter 2008 Financial Results
8. Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
9. Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast
10. Advanced Bionics Reaches Resolution With FDA, Settles Financial Suit
11. China Biologic Products Honored with the Advanced Technology Certification for Foreign-Funded Enterprises
Post Your Comments:
(Date:11/5/2009).... 5 Imagenetix, Inc. (OT...iam Spencer, President and CEO of Imagenetix, will...al LD MICRO Conference on Thursday, December 3rd, ... ,, About LD MICRO ,, LD MICRO is a by-invit... undervalued companies in the micro-cap space. Sin...
(Date:11/5/2009)...l on Thursday, November 5, 2009 at 4:30 p.m. Easte...RNewswire-FirstCall/ - OncoGenex Pharmaceuticals, ... ) today reported unaudited financial results for ...30, 2009 and reviewed the Company,s highlights for...nsolidated results reflect the operations of OncoG...
(Date:11/5/2009)..., Nov. 5 BioSpecifics Te...ical company developing first-in-class collagenase...ults for the third quarter ended September 30, 200...ber of this year, the FDA,s Arthritis Advisory Com... the approval of XIAFLEX(TM) for the treatment of ...
(Date:11/5/2009)...xas, Nov. 5 Wound Manage...hat it has entered into a Letter of Intent to purc...th Technologies, Inc. (OTC Bulletin Board: VHGI). ...n cash and debt, 4,000,000 shares of WNDM and a ro...the Veriscrip technology being acquired from VHGI....
Breaking Biology Technology:Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3[0] Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air[0] OncoGenex Reports Third Quarter 2009 Financial Results[0] BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results[0] OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock
...rmaceuticals Inc. (Nasdaq: VNDA ), a biopharmace...ercialization of clinical-stage product candidates...nced financial and operational results for the fir...rted a net loss of $6.5 million for the first quar...th quarter of 2008. Total expenses for the first ...
..., - Increases Accessibility to Market-Leading ...ing publisher of scientific, technical, and,medica...ay that ten new eBook,Specialty Collections have l...,its online clinical reference tool. This launch p...ialty content in Dermatology, Dermatologic Surgery...
...e as usual pending Nasdaq listing review , , REYK... DCGN ) announced that it has this evening recei...eview Council stating that the Council has called ...q Listing Qualifications Panel regarding the delis... Stock Market. Pending the completion of this revi...
Other Biology Technology:Vanda Pharmaceuticals Reports First Quarter 2009 Results 2Vanda Pharmaceuticals Reports First Quarter 2009 Results 3Vanda Pharmaceuticals Reports First Quarter 2009 Results 4Vanda Pharmaceuticals Reports First Quarter 2009 Results 5Vanda Pharmaceuticals Reports First Quarter 2009 Results 6Vanda Pharmaceuticals Reports First Quarter 2009 Results 7Vanda Pharmaceuticals Reports First Quarter 2009 Results 8Vanda Pharmaceuticals Reports First Quarter 2009 Results 9Vanda Pharmaceuticals Reports First Quarter 2009 Results 10Elsevier Launches Ten New eBook Specialty Collections on MD Consult 2Elsevier Launches Ten New eBook Specialty Collections on MD Consult 3Nasdaq Stays Suspension of Trading in deCODE Stock 2Nasdaq Stays Suspension of Trading in deCODE Stock 3(Date:11/9/2009)... marine plants called phytoplankton are flourishin...t and rapid melting of ice shelves and glaciers ar...nisation is having a beneficial impact on climate ... to the sea-bed where it can store carbon for thou...ek in the journal Global Change Biology , scienti...
(Date:11/9/2009)...ren with cancer, the hopeful news is that pediatri...s. Among the bad newstreatments that enable surviv...ith cancer who have reached puberty currently have...e undergoing cancer treatment, they may have their...r boys, however, do not produce sperm, although th...
(Date:11/9/2009)...N.Y. Oncologists have had their hands tied becaus...ns that disable a protein called p53. As a critica...ncer-fighting operations within cells. When cells ...t be treated. , These tumors might be tough, bu...m Cold Spring Harbor Laboratory (CSHL). The chink ...
Breaking Biology News(10 mins):Antarctica glacier retreat creates new carbon dioxide store 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3FDA Clears a Test for Ovarian Cancer 4972 1FDA Clears a Test for Ovarian Cancer 4972 2Professor Uses H1N1 as a Teaching Tool 56956 1Professor Uses H1N1 as a Teaching Tool 56956 2Professor Uses H1N1 as a Teaching Tool 56956 3Muslim Coalition to Host D C Hearing on Health Care Reform 56951 1Muslim Coalition to Host D C Hearing on Health Care Reform 56951 2...ease is available in Spanish . , The SUPERCABL...aterial Science of Barcelona (ICMAB-CSIC), at the ...nd the company Nexans, received the NOVARE Prize i...y ENDESA. The 500,000 prize will be invested in de...south of Europe and the most advanced in the world...
... MA, AND WASHINGTON, DCThe University of Massachus...f Washington announced today that they have entere...(LSE: OXB), a gene therapy company, that grants t...atent rights. , The technology was invented by ..., and Craig C. Mello, PhD, and their colleagues. T...
...tor-in-Chief of Experimental Biology and Medicine ...n for expansion of the journal and enhancement of ...ogy and Medicine (SEBM) into Asia. The plan, whic...ves bringing outstanding Asian researchers onto th...om amongst the leaders in Asian Biomedical Science...
Other Biology News:CSIC and UAB will build the most advanced superconductor cable for electricity network 2CSIC and UAB will build the most advanced superconductor cable for electricity network 3UMMS and CIW grant key RNAi rights to Oxford Biomedica 2Experimental Biology and Medicine announces expansion into Asia, opens new office 2Experimental Biology and Medicine announces expansion into Asia, opens new office 3Acridine orange, hemizinc salt from Research Organics, Inc.
Acridine orange 10-nonyl bromide from AnaSpec
Anti-rat Ig HRP detection kit from BD Biosciences Pharmingen
Wash Solution from CHEMICON
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |